Literature DB >> 27800052

Is it time to end lone-wolf medicine?

Andrew Loblaw1.   

Abstract

Year:  2016        PMID： 27800052      PMCID： PMC5085910          DOI： 10.5489/cuaj.4163

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  9 in total

Review 1.  Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement.

Authors:  Stephen J Freedland; R Bryan Rumble; Antonio Finelli; Ronald C Chen; Susan Slovin; Mark N Stein; David S Mendelson; Colin Wackett; Howard M Sandler
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

Review 2.  Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis.

Authors:  Scott C Morgan; Tricia S Waldron; Libni Eapen; Linda A Mayhew; Eric Winquist; Himu Lukka
Journal:  Radiother Oncol       Date:  2008-05-22       Impact factor: 6.280

3.  Quality of Radiation Therapy Referral and Utilisation Post-prostatectomy: A Population-based Study of Time Trends.

Authors:  C J Jin; M D Brundage; E F Cook; Q Miao; T P Hanna
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-07-25       Impact factor: 4.126

4.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Laurence Collette; Paul van Cangh; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Jean-Marie Maréchal; Pierre Scalliet; Karin Haustermans; Marianne Piérart
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

5.  Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer.

Authors:  Keith J Kowalczyk; Xiangmei Gu; Paul L Nguyen; Stuart R Lipsitz; Quoc-Dien Trinh; John H Lynch; Sean P Collins; Jim C Hu
Journal:  Urol Oncol       Date:  2013-12-08       Impact factor: 3.498

6.  Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.

Authors:  Ian M Thompson; Richard K Valicenti; Peter Albertsen; Brian J Davis; S Larry Goldenberg; Carol Hahn; Eric Klein; Jeff Michalski; Mack Roach; Oliver Sartor; J Stuart Wolf; Martha M Faraday
Journal:  J Urol       Date:  2013-05-21       Impact factor: 7.450

7.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

8.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Authors:  Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E David Crawford
Journal:  J Urol       Date:  2009-01-23       Impact factor: 7.450

Review 9.  Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.

Authors:  Christopher J D Wallis; Alyson L Mahar; Richard Choo; Sender Herschorn; Ronald T Kodama; Prakesh S Shah; Cyril Danjoux; Steven A Narod; Robert K Nam
Journal:  BMJ       Date:  2016-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.